Circulating tumour cells for guiding antibody‒drug conjugate therapy: Role of artificial intelligence.

Yaghoubi Naei V, Dabiri M, Chen L, Li J, Wang IH, Lin G, Ebrahimi Warkiani M

Open source

DOI
10.1002/ctm2.70748
Published
2026 Sep
Container
Clinical and translational medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.70748,
  title = {Circulating tumour cells for guiding antibody‒drug conjugate therapy: Role of artificial intelligence.},
  author = {Yaghoubi Naei V and Dabiri M and Chen L and Li J and Wang IH and Lin G and Ebrahimi Warkiani M},
  year = {2026},
  journal = {Clinical and translational medicine},
  doi = {10.1002/ctm2.70748},
  url = {https://doi.org/10.1002/ctm2.70748}
}

RIS

TY  - JOUR
TI  - Circulating tumour cells for guiding antibody‒drug conjugate therapy: Role of artificial intelligence.
AU  - Yaghoubi Naei V
AU  - Dabiri M
AU  - Chen L
AU  - Li J
AU  - Wang IH
AU  - Lin G
AU  - Ebrahimi Warkiani M
PY  - 2026
JO  - Clinical and translational medicine
DO  - 10.1002/ctm2.70748
UR  - https://doi.org/10.1002/ctm2.70748
ER  - 

APA

V, Y. N., M, D., L, C., J, L., IH, W., G, L., & M, E. W. (2026). Circulating tumour cells for guiding antibody‒drug conjugate therapy: Role of artificial intelligence.. Clinical and translational medicine. https://doi.org/10.1002/ctm2.70748

Source records